Oculis Holding AG (OCS) Financials

OCS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 303.7 million 58.9 million
Dec. 31, 2025 297.7 million 50.3 million
Sept. 30, 2025 210.7 million 46.8 million
June 30, 2025 229.1 million 48.6 million

OCS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -19.4 million ?
Dec. 31, 2025 -20.2 million 5.4 million
Sept. 30, 2025 -17.0 million 5.7 million
June 30, 2025 -21.9 million 5.7 million

OCS Net Income

No data available :(

OCS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 276.4 million - 2.3 million
Dec. 31, 2025 268.8 million - 2.3 million
Sept. 30, 2025 58.3 million - 3.1 million
June 30, 2025 202.2 million - 1.3 million

OCS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 73.5 million
Dec. 31, 2025 70.6 million
Sept. 30, 2025 66.1 million
June 30, 2025 65.9 million

OCS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 8937 17.8 million 10.0 million -
Dec. 31, 2025 46645 16.6 million 9.7 million -
Sept. 30, 2025 155699 17.7 million 8.1 million -
June 30, 2025 158918 18.8 million 6.8 million -

OCS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 196550
Dec. 31, 2025 - -
Sept. 30, 2025 305120 -
June 30, 2025 329188 18.8 million

OCS

Price: $11.09

52 week price:
10.71
34.48

Earnings Per Share: -2.16 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Market Capitalization: 735.8 million

Links: